LOS ANGELES, CA, (NAMC) - Tustin, California based Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM) filed a registration statement with the U.S. Securities and Exchange Commission to periodically sell upwards of 15 million shares of the company’s common stock for general corporate purposes.

According to the company this may include expenses related to research, expansion, operating expenses or clinical trials. The company may opt to do this in multiple stages.

Peregrine is trading at $1.42 , down 20 cents or 12.27%  on 3.8 million shares traded.

Michael Rossi
Business News Correspondent
NAMC Newswire
www.namcnewswire.com

This article can be republished either online or in print as long as credit is given to the author and the NAMC Newswire.
 
NAMC Newswire articles can now be listened to on StreetIQ.com
http://www.streetiq.com/dir/NAMC.shtml

To keep up to date with companies that we report on just register to receive the FREE Wall Street to Main Street Daily Newsletter. We feature companies that trade on the NYSE, AMEX, NASDAQ, OTCBB and Overseas, Keeping our readers informed daily. Just go to our site and register, it’s simple and free, www.namcnewswire.com/newsletter . Also be sure to visit the NAMC radio at www.namcnewswire.com/namcradio for the latest reports, interviews and corporate updates featured on the NAMC Newswire.